1. A call to action to inform patient‐centred approaches to obesity management: Development of a disease‐illness model. Issue 3 (11th April 2019) Authors: Fastenau, John; Kolotkin, Ronette L.; Fujioka, Ken; Alba, Maria; Canovatchel, William; Traina, Shana Journal: Clinical obesity Issue: Volume 9:Issue 3(2019) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Advances in Porous Silicon–Based Nanomaterials for Diagnostic and Therapeutic Applications. Issue 1 (10th October 2018) Authors: Tieu, Terence; Alba, Maria; Elnathan, Roey; Cifuentes‐Rius, Anna; Voelcker, Nicolas H. Journal: Advanced therapeutics Issue: Volume 2:Issue 1(2019) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Canagliflozin: a sodium glucose co‐transporter 2 inhibitor for the treatment of type 2 diabetes mellitus. Issue 1 (25th August 2015) Authors: Rosenthal, Norm; Meininger, Gary; Ways, Kirk; Polidori, David; Desai, Mehul; Qiu, Rong; Alba, Maria; Vercruysse, Frank; Balis, Dainius; Shaw, Wayne; Edwards, Robert; Bull, Scott; Di Prospero, Nicholas; Sha, Sue; Rothenberg, Paul; Canovatchel, William; Demarest, Keith Journal: Annals of the New York Academy of Sciences Issue: Volume 1358:Issue 1(2015) Page Start: 28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Carbon-stabilized porous silicon as novel voltammetric sensor platforms. (1st May 2021) Authors: Pérez-Ràfols, Clara; Guo, Keying; Alba, Maria; Toh, Rou Jun; Serrano, Núria; Voelcker, Nicolas H.; Prieto-Simón, Beatriz Journal: Electrochimica acta Issue: Volume 377(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Diabetic ketoacidosis in patients with type 2 diabetes treated with sodium glucose co‐transporter 2 inhibitors versus other antihyperglycemic agents: An observational study of four US administrative claims databases. Issue 12 (27th August 2019) Authors: Wang, Lu; Voss, Erica A.; Weaver, James; Hester, Laura; Yuan, Zhong; DeFalco, Frank; Schuemie, Martijn J.; Ryan, Patrick B.; Sun, Don; Freedman, Amy; Alba, Maria; Lind, Joan; Meininger, Gary; Berlin, Jesse A.; Rosenthal, Norman Journal: Pharmacoepidemiology and drug safety Issue: Volume 28:Issue 12(2019) Page Start: 1620 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Differential functionalisation of the internal and external surfaces of carbon-stabilised nanoporous silicon. Issue 55 (21st June 2019) Authors: Alba, Maria; Robin, Morgane; Menzies, Donna; Gengenbach, Thomas R.; Prieto-Simon, Beatriz; Voelcker, Nicolas H. Journal: Chemical communications Issue: Volume 55:Issue 55(2019) Page Start: 8001 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Effects of canagliflozin on initiation of insulin and other antihyperglycaemic agents in the CANVAS Program. Issue 11 (24th August 2020) Authors: Matthews, David R.; Wysham, Carol; Davies, Melanie; Slee, April; Alba, Maria; Lee, Mary; Perkovic, Vlado; Mahaffey, Kenneth W.; Neal, Bruce Journal: Diabetes, obesity & metabolism Issue: Volume 22:Issue 11(2020) Page Start: 2199 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus from Latin America. (3rd March 2016) Authors: Lavalle-González, Fernando J.; Eliaschewitz, Freddy G.; Cerdas, Sonia; Del Pilar Chacon, Maria; Tong, Cindy; Alba, Maria Journal: Current medical research and opinion Issue: Volume 32:Number 3(2016:Mar.) Page Start: 427 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Efficacy and safety of glucagon‐like peptide‐1/glucagon receptor co‐agonist JNJ‐64565111 in individuals with obesity without type 2 diabetes mellitus: A randomized dose‐ranging study. Issue 2 (21st January 2021) Authors: Alba, Maria; Yee, Jaqueline; Frustaci, Mary Ellen; Samtani, Mahesh N.; Fleck, Penny Journal: Clinical obesity Issue: Volume 11:Issue 2(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Efficacy and safety of glucagon‐like peptide‐1/glucagon receptor co‐agonist JNJ‐64565111 in individuals with type 2 diabetes mellitus and obesity: A randomized dose‐ranging study. Issue 2 (21st January 2021) Authors: Di Prospero, Nicholas A.; Yee, Jaqueline; Frustaci, Mary E.; Samtani, Mahesh N.; Alba, Maria; Fleck, Penny Journal: Clinical obesity Issue: Volume 11:Issue 2(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗